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A
s one of the founding members 
of the European Molecular Biol-
ogy Laboratory (EMBL) and a 
leading voice in European and American 
science advocacy organizations, Kai Si-
mons has had an enduring infl  uence on 
generations of scientists. His work on 
membrane organization has also made a 
deep impact in cell biology.
Simons, who is now based at the Max 
Planck Institute in Dresden, credits much 
of his career success to others (1), begin-
ning with his father, who 
set him on the path to bio-
medical research, and then 
Leevi Kääriäinen, who in-
troduced him to Semliki 
Forest Virus—which would 
subsequently become a fo-
cus of his early work on cell 
membrane traffi  cking path-
ways (2, 3). Later, at the 
newly formed EMBL, Si-
mons  assembled a multi-
disciplinary team of re-
searchers to study how certain proteins, 
together with certain lipids, dynamically 
segregate into subdomains in the plasma 
membrane (4, 5). These subdomains, 
termed “lipid rafts,” serve as platforms for 
protein transport and launching pads for 
signaling pathways.
The lipid raft concept revolutionized 
our understanding of the role of mem-
branes in cell biology, but it has suffered 
its share of controversy. Simons and his 
colleagues in the fi  eld have nonetheless 
persevered, and continue to refi  ne their 
understanding of these important struc-
tures (6). He talked to us about his rafting 
adventures, and where he and his col-
leagues are now headed.
A PRACTICAL MAN
Where did you grow up?
I grew up in Helsinki, Finland. My father 
was a farmer’s son, and he was the fi  rst 
person to get out of his farming commu-
nity, which was 500 km north of Helsinki. 
He became a professor of physics, so I 
grew up with a lot of physicists around 
me; my father’s department would host 
seminars, and the speakers would often be 
invited for dinner at our home. So some 
very famous people came to our house.
What famous people did you meet?
Well, the most famous person was Albert 
Einstein. When I was 11 years old, my fa-
ther spent a sabbatical in Princeton at the 
Institute for Advanced Study, and he took 
us with him. We saw Einstein around the 
campus a lot; I remember that he always 
had an umbrella with him, no matter what 
the weather was like. And one day, there 
he was: a smiling man standing right in 
front of us. We asked to take a picture of 
him, and he said yes. I still have that pic-
ture that my brother and I took.
So did you originally want to be a 
physicist?
Oh, yes. I wanted to follow in my fa-
ther’s footsteps. But my father—ever the 
farmer’s son—was a practical man. He 
told me he didn’t think I was up to be-
coming a physicist. He advised me to 
study medicine instead, because then I 
could always do research if I didn’t like 
practicing medicine.
It turns out that was good advice, al-
though it was defi  nitely a struggle at fi  rst. 
One of my early research projects in-
volved purifying a protein called intrinsic 
factor—which is needed for vitamin B12 
absorption—from gastric juice. We needed 
about 30 liters of gastric juice for this, 
so I volunteered to be intubated for the 
gastric juice collection, but the fi  rst time 
I was intubated I nearly died because I 
got a laryngeal edema.
WILLING TO SACRIFICE
It sounds like you’ve made sacriﬁ  ces for 
your research.
Lots of people are willing to sacrifi  ce for 
research. Once, I had my whole medical 
class, 60 or 70 people, donate saliva for 
me so that I could purify vitamin B12, 
binding proteins from it. I got permission 
from the professor, during a lecture in ob-
stetrics, to have everyone chew paraffi  n 
and spit their saliva into a bowl. There 
they all were, discussing obstetrics, and 
interrupting themselves to spit [laughs]. It 
was quite a scene!
A real team effort!
You could say that. But actually my entire 
career in science has been based on work-
ing together with others, and trying to put 
together teams. As a postdoc at the Rock-
efeller University, I saw this incredible 
density of talent and resources—but I also 
saw that there was very little collaboration, 
even within laboratories. 
When I returned to Finland I was con-
vinced that the only way to survive doing 
research there was to pool my resources 
with others. I got together with two other 
researchers, Leevi Kääriäinen and Ossi 
Renkonen, to form a kind of research troi-
ka. Each of us brought specifi  c strengths 
to the team to further our interests. I still 
think this kind of collaboration is essential 
if you want to do groundbreaking work.
Your work from this time provided 
fundamental information on lipid 
membranes.
Using everything from viruses to molecular tweezers, Simons has made 
a career of studying the cell membrane.
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Yes. Our research troika—together with 
Ari Helenius—was able to do a methodi-
cal study about how different detergents 
solubilize membranes, because we had 
this extremely simple system in which to 
study it: Semliki Forest Virus. This vi-
rus’s membrane had only one viral pro-
tein. If we had been using a complex cel-
lular membrane, the data would have 
been uninterpretable.
But then you moved to Germany.
I’d been given the opportunity to join the 
new European Molecular Biology Labo-
ratory, which was being formed under 
John Kendrew. I went there on a three-year 
contract together with Ari Helenius—who 
was married to my sister—with the idea 
that we would return to Finland after-
ward. I did eventually get the job I wanted 
in Finland, but the funding situation there 
was so bad—on a level with Portugal—
that I decided to stay at EMBL. Now, of 
course, Finland spends more per capita 
on scientifi   c funding than the United 
States; only Sweden spends more. But I am 
glad I stayed at EMBL, because I had the 
opportunity to help infl  uence the institute’s 
direction as it grew.
DYNAMIC FUTURE
And this was when you ﬁ  rst started 
formalizing your ideas about lipid rafts.
By that time I had gotten interested in 
looking at how membranes and proteins 
are distributed to the apical and basola-
teral surfaces of MDCK cells. I became 
enamored with the concept of membrane 
compartmentalization and recruited Ger-
rit van Meer from Utrecht [University] to 
work with me on it. Our early studies 
showed that lipids and proteins are sorted 
together in the trans-Golgi, and that the 
glycolipids and apical proteins segregate 
into a platform that buds off from the Golgi 
and is brought by a carrier to the apical 
membrane. This was our fi  rst conceptuali-
zation of lipid rafts.
The lipid raft concept became enormously 
popular, then equally controversial.
Yes. The methodology everyone initially 
used to study lipid rafts was detergent re-
sistance: if you put Triton on a membrane, 
any material that was insoluble at four de-
grees was considered a part of a lipid raft. 
Of course this was too simple-minded. 
People would try to manipulate things to 
get the protein they worked on to be in-
soluble. This was easy to do; you just had 
to use a little less detergent. So this led to 
an adverse reaction and the whole idea of 
lipid rafts became controversial. For a 
long time it was diffi  cult to publish, and 
I thought I would never see the light at the 
end of the tunnel. There are quite a number 
of people out there still who think rafts 
are an artifact.
What are your thoughts on lipid rafts 
today?
Over the last two years 
our methodology has 
improved so much. 
Those who work in the 
fi   eld now know that 
there is no current alter-
native explanation for 
the segregation behav-
ior that is the basis for 
the raft concept. What 
has changed is that we 
now understand rafts to 
be more dynamic. The 
resting state is a fl  uctu-
ating state where the li-
pid and protein raft components continually 
come together, and dissociate. Rafts coa-
lesce into a platform by oligomerizing, but 
even these platforms are transitory entities. 
The problem we now face is how to de-
scribe this collective behavior; there are 
many participants in the oligomerization 
reaction—thousands of lipids and proteins 
moving together at the same time. How do 
you study such a phenom-
enon? It’s not simple. But 
with the infusion of bio-
physics into this fi  eld, we 
have many new tools—
such as single molecule 
and STED spectroscopy—
that are beginning to give 
us glimpses of the dynam-
ics of membrane subcom-
partmentalization. 
We have also recently 
shown that plasma mem-
branes can phase separately into microme-
ter subdomains just as simple lipid mod-
el systems do, but that such phase sepa-
ration is prevented in living cells…so 
we’re still learning about rafts, and re-
fi  ning our understanding of their roles 
in cells. We’re excited about where the 
fi  eld is headed. 
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“We visualize 
rafts as 
being highly 
dynamic; 
the resting 
state is a 
fluctuating 
state.”
Transferrin receptor (green) phase separates from GM1 glycolipids (red) in membrane spheres 
derived from cells.
Simons takes a ﬁ  rm position on lipid rafts.